The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Government & LegalFull Access

Risk Management Amid a Global Pandemic

Published Online:https://doi.org/10.1176/appi.pn.2020.5a38

Abstract

Be sure you know the current regulations and best practices regarding the provision of patient care during the COVID-19 pandemic.

Photo: Anne Huben-Kearney, R.N., B.S.N., M.P.A.

Thank you for your strength and resilience in providing vital mental health services to your patients, colleagues, friends, and family during this challenging time.

Why talk about risk management during the COVID-19 pandemic? Risk mitigation is always critical, especially in a global emergency. Use of best practices, such as those listed below, ensures that your practice is consistent and safe.

Telehealth Considerations

The standard of care provided via telehealth is the same as the standard of care for traditional face-to-face encounters, including patient evaluation and assessment, treatment plans, medication, and documentation.

If planning to provide telepsychiatry services, choose a HIPAA-compliant telehealth vendor and obtain a Business Associate Agreement (BAA) to ensure data protection and security. If using one of the non-HIPAA-compliant platforms, such as Skype or FaceTime, which are temporarily allowed during this national emergency, enable all available encryption and privacy modes.

Regardless of the technology platform, obtain informed consent from each patient authorizing the use of telehealth. Include in the discussion the potential for privacy and security breaches; emphasize the need for interactions to be conducted in a location that provides auditory and visual privacy; and point out that Skype, FaceTime, or similar services are not secure, HIPAA-compliant systems. Document the patient’s understanding prior to use.

Providing Care for Patients Out of State

One of the major changes impacting care during the COVID-19 crisis involves licensure in the state where the patient is located. During this pandemic, governors in many states have issued executive orders waiving licensure requirements, and many have expedited temporary licenses for out-of-state physicians wishing to provide telehealth services to the residents of their state. Check the executive orders for the states in which your patients are now located. Refer to the Council of State Governments’ “COVID-19 Resources for State Legislators” for a listing of the executive orders.

Prescribing Controlled Substances

With the COVID-19 public health emergency, the Drug Enforcement Administration (DEA) has suspended the requirement of the Ryan Haight Act that a health care professional conduct an initial, in-person exam of a patient before electronically prescribing a controlled substance. Comply with state laws or regulations on prescribing controlled substances that may not have been suspended.

If practicing telepsychiatry in multiple states, only one DEA registration is required under federal law to dispense controlled substances in those states. Refer to the Drug Enforcement Agency Diversion Control Division’s COVID-19 information page.

Potential Exposure to COVID-19 in the Office

If notified that a patient has or highly suspects he or she has the COVID-19 virus, best practice is to contact your patients who may have encountered that individual. Inform the patients that another patient has tested positive or highly suspects he or she may have the COVID-19 virus and was at the office on the same day. To maintain privacy compliance under HIPAA, do not provide names, appointment times, or information that may make it possible to identify that individual.

If Asked to Release Information

The HIPAA Privacy Rule permits disclosure of protected health information without individual authorization to a public health authority, such as the Centers for Disease Control and Prevention or state/local health departments. Limit the disclosure to the “minimum necessary,” such as the name and phone number of the patient, but do not release the clinical record or patient diagnosis. ■

This information is provided as a risk management resource for Allied World policyholders and should not be construed as legal or clinical advice. This material may not be reproduced or distributed without the express, written permission of Allied World Assurance Company Holdings Ltd, a Fairfax company (“Allied World”). Risk management services are provided by or arranged through AWAC Services Company, a member company of Allied World. All Rights Reserved.

Anne Huben-Kearney, R.N., B.S.N., M.P.A., is the assistant vice president of the Risk Management Group, AWAC Services Company, a member company of Allied World.